202 related articles for article (PubMed ID: 1327387)
1. GR94839, a kappa-opioid agonist with limited access to the central nervous system, has antinociceptive activity.
Rogers H; Birch PJ; Harrison SM; Palmer E; Manchee GR; Judd DB; Naylor A; Scopes DI; Hayes AG
Br J Pharmacol; 1992 Aug; 106(4):783-9. PubMed ID: 1327387
[TBL] [Abstract][Full Text] [Related]
2. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.
Barber A; Bartoszyk GD; Bender HM; Gottschlich R; Greiner HE; Harting J; Mauler F; Minck KO; Murray RD; Simon M
Br J Pharmacol; 1994 Dec; 113(4):1317-27. PubMed ID: 7889287
[TBL] [Abstract][Full Text] [Related]
3. Central and peripheral actions of the novel kappa-opioid receptor agonist, EMD 60400.
Barber A; Bartoszyk GD; Greiner HE; Mauler F; Murray RD; Seyfried CA; Simon M; Gottschlich R; Harting J; Lues I
Br J Pharmacol; 1994 Mar; 111(3):843-51. PubMed ID: 8019761
[TBL] [Abstract][Full Text] [Related]
4. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. I. A mixed opioid agonist with potent antinociceptive activity.
Gengo PJ; Pettit HO; O'Neill SJ; Wei K; McNutt R; Bishop MJ; Chang KJ
J Pharmacol Exp Ther; 2003 Dec; 307(3):1221-6. PubMed ID: 14534368
[TBL] [Abstract][Full Text] [Related]
5. A series of novel, highly potent and selective agonists for the kappa-opioid receptor.
Hayes AG; Birch PJ; Hayward NJ; Sheehan MJ; Rogers H; Tyers MB; Judd DB; Scopes DI; Naylor A
Br J Pharmacol; 1990 Dec; 101(4):944-8. PubMed ID: 1964823
[TBL] [Abstract][Full Text] [Related]
6. CI-977, a novel and selective agonist for the kappa-opioid receptor.
Hunter JC; Leighton GE; Meecham KG; Boyle SJ; Horwell DC; Rees DC; Hughes J
Br J Pharmacol; 1990 Sep; 101(1):183-9. PubMed ID: 2178014
[TBL] [Abstract][Full Text] [Related]
7. A potent new class of kappa-receptor agonist: 4-substituted 1-(arylacetyl)-2-[(dialkylamino)methyl]piperazines.
Naylor A; Judd DB; Lloyd JE; Scopes DI; Hayes AG; Birch PJ
J Med Chem; 1993 Jul; 36(15):2075-83. PubMed ID: 8393489
[TBL] [Abstract][Full Text] [Related]
8. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
[TBL] [Abstract][Full Text] [Related]
9. BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice.
Broom DC; Guo L; Coop A; Husbands SM; Lewis JW; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2000 Sep; 294(3):1195-200. PubMed ID: 10945877
[TBL] [Abstract][Full Text] [Related]
10. 4-[(Alkylamino)methyl]furo[3,2-c]pyridines: a new series of selective kappa-receptor agonists.
Naylor A; Judd DB; Scopes DI; Hayes AG; Birch PJ
J Med Chem; 1994 Jul; 37(14):2138-44. PubMed ID: 8035420
[TBL] [Abstract][Full Text] [Related]
11. Analgesic and antiinflammatory effects of two novel kappa-opioid peptides.
Binder W; Machelska H; Mousa S; Schmitt T; Rivière PJ; Junien JL; Stein C; Schäfer M
Anesthesiology; 2001 Jun; 94(6):1034-44. PubMed ID: 11465595
[TBL] [Abstract][Full Text] [Related]
12. Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity.
DeHaven-Hudkins DL; Burgos LC; Cassel JA; Daubert JD; DeHaven RN; Mansson E; Nagasaka H; Yu G; Yaksh T
J Pharmacol Exp Ther; 1999 Apr; 289(1):494-502. PubMed ID: 10087042
[TBL] [Abstract][Full Text] [Related]
13. Putative kappa-2 opioid agonists are antihyperalgesic in a rat model of inflammation.
Ho J; Mannes AJ; Dubner R; Caudle RM
J Pharmacol Exp Ther; 1997 Apr; 281(1):136-41. PubMed ID: 9103490
[TBL] [Abstract][Full Text] [Related]
14. Peripheral component in the enhanced antinociceptive effect of systemic U-69,593, a kappa-opioid receptor agonist in mononeuropathic rats.
Catheline G; Guilbaud G; Kayser V
Eur J Pharmacol; 1998 Sep; 357(2-3):171-8. PubMed ID: 9797033
[TBL] [Abstract][Full Text] [Related]
15. Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors.
Vanderah TW; Largent-Milnes T; Lai J; Porreca F; Houghten RA; Menzaghi F; Wisniewski K; Stalewski J; Sueiras-Diaz J; Galyean R; Schteingart C; Junien JL; Trojnar J; Rivière PJ
Eur J Pharmacol; 2008 Mar; 583(1):62-72. PubMed ID: 18282565
[TBL] [Abstract][Full Text] [Related]
16. Opioid systems in the response to inflammatory pain: sustained blockade suggests role of kappa- but not mu-opioid receptors in the modulation of nociception, behaviour and pathology.
Millan MJ; Colpaert FC
Neuroscience; 1991; 42(2):541-53. PubMed ID: 1654538
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological properties of R-84760, a novel kappa-opioid receptor agonist.
Fujibayashi K; Sakamoto K; Watanabe M; Iizuka Y
Eur J Pharmacol; 1994 Aug; 261(1-2):133-40. PubMed ID: 8001635
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of novel peripherally restricted kappa-opioid receptor agonists.
Kumar V; Guo D; Cassel JA; Daubert JD; Dehaven RN; Dehaven-Hudkins DL; Gauntner EK; Gottshall SL; Greiner SL; Koblish M; Little PJ; Mansson E; Maycock AL
Bioorg Med Chem Lett; 2005 Feb; 15(4):1091-5. PubMed ID: 15686919
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the antinociceptive effects of TRK-820 in the rat.
Endoh T; Tajima A; Suzuki T; Kamei J; Narita M; Tseng L; Nagase H
Eur J Pharmacol; 2000 Jan; 387(2):133-40. PubMed ID: 10650153
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
